輔酶 Q10 (輔酵素 Q10) Coenzyme Q10 × 女性生育力
結論：證據支持但有警示
2024 年 Annals of Medicine 系統性回顧（6 RCT、1529 名 DOR 女性）顯示 CoQ10 預處理可顯著提升 IVF/ICSI 臨床懷孕率（OR=1.
B 🟡 B 初步證據 附警語發布 ⚠️ medium — moderate promotional content
2024 年 Annals of Medicine 系統性回顧（6 RCT、1529 名 DOR 女性）顯示 CoQ10 預處理可顯著提升 IVF/ICSI 臨床懷孕率（OR=1.84）、取卵數與優質胚胎數，並降低流產率（OR=0.38），這在 DOR/高齡受試族群為一致的正向訊號。
然而證據侷限於 IVF/DOR 子族群、樣本量中等、Cochrane 2020 對整體抗氧化劑僅給「低至極低品質證據」評等，且 ESHRE 2019/2023/2025 與 ASRM 2022 兩大權威生殖醫學會均明確「不建議常規使用」，加上 TFDA 與 FDA 禁止生育力療效宣稱，整體應評為 B（中等證據、有 RCT 正向訊號但伴隨權威保留與適用族群限制）。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.64
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
B · 附警語發布
信心度
83%
證據方向一致性高
證據層級
E1
Cochrane 高品質系統性回顧／統合分析
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.636
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Antioxidants for female subfertility (Cochrane Review, CD007807.pub4)
結論：Across 63 RCTs/7760 women, antioxidants as a class may increase live birth (OR 1.81, 95% CI 1.36-2.43, 13 RCTs, 1227 women) and clinical pregnancy (OR 1.65, 95% CI 1.43-1.89, 35 RCTs, 5165 women) but the evidence is GRADE very-low to low certainty so authors are uncertain of benefit; no difference in miscarriage (OR 1.13, 95% CI 0.82-1.55).
前往 PubMed Antioxidants and Fertility in Women with Ovarian Aging: A Systematic Review and Meta-Analysis
結論：Pooling 20 RCTs/2617 women, antioxidants increased retrieved oocytes and high-quality embryo rate and raised clinical pregnancy; in subgroup analysis CoQ10 was more effective than melatonin/myo-inositol/vitamins, with the optimal regimen ~30 mg/d for 3 months pre-stimulation and clearest benefit in DOR women aged <35.
前往 PubMed Clinical evidence of coenzyme Q10 pretreatment for women with diminished ovarian reserve undergoing IVF/ICSI: a systematic review and meta-analysis
結論：Across 6 RCTs/1529 DOR women, CoQ10 pretreatment raised clinical pregnancy rate (OR 1.84, 95% CI 1.33-2.53, p=0.0002), oocytes retrieved (MD 1.30, 95% CI 1.21-1.40) and lowered cycle cancellation (OR 0.60) and miscarriage (OR 0.38, 95% CI 0.15-0.98, p=0.05, borderline); live birth was NOT a reported outcome and authors caution the included trials were small with poorly described methods.
前往 PubMed Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial
結論：CoQ10 increased retrieved oocytes (median 4 vs fewer), fertilization rate (67.49%) and high-quality embryos and reduced cancelled transfers (8.33% vs 22.89%, p=0.04), but clinical pregnancy and live birth rates only trended higher and did NOT reach statistical significance (186 randomized, 169 evaluated: 76 CoQ10 vs 93 control).
前往 PubMed Coenzyme Q10 Impact on Ovarian Reserve Measures and the Intra-Cytoplasmic Sperm Injection (ICSI) Outcomes in Women with Poor Ovarian Response: A Randomized Controlled Study
結論：CoQ10 significantly improved oocyte count, peak E2, antral follicle count (p=0.001), endometrial thickness (p=0.004) and embryos transferred (p=0.011), but chemical and clinical pregnancy rates and completed cycles were equivalent between groups (non-significant).
前往 PubMed L4a US FDA
謹慎
not generally recognized as safe and effective for the referenced uses and therefore are considered "new drugs" 來源↗
L4b EU EFSA
反對
a cause and effect relationship has not been established between the consumption of coenzyme Q10 and the claimed effects 來源↗
L4c UK NHS
謹慎
Advise people with migraine that the food supplement riboflavin (400 mg once a day) may be effective in reducing migraine frequency and intensity for some people. 來源↗
L4d TW TFDA / 衛福部
謹慎
訂定「食品原料輔酵素Q10 (Coenzyme Q10)之使用限制及標示規定」 來源↗
L4e WHO
未表態
— 本適應症無對應資料
L5a NIH Office of Dietary Supplements
謹慎
— 本適應症無對應資料
L5b Mayo Clinic
謹慎
Coenzyme Q10 may improve egg quality in mice, but study results haven't been confirmed in humans. ... Until researchers more clearly define the risks and benefits of fertility herbs and supplements, conventional treatment for infertility appears to be the best option. 來源↗
L5c Cleveland Clinic
謹慎
CoQ10 has been studied for exercise recovery, diabetes, skin health and collagen production, high blood pressure, and fertility — but research is limited, and there's no conclusive evidence to show that CoQ10 offers these benefits. 來源↗
L5d Harvard Health
中性
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
謹慎
low or very low certainty of evidence, effect on live birth uncertain, routine use not recommended. 來源↗
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 中度
低中高
📍立場總覽
PTT 好孕板 (GoodPregnan)、Dcard 親子板與 BabyHome 對 Q10 養卵普遍持支持態度，被視為備孕「養卵三寶/五寶」之一；多數備孕女性會在 35 歲以後或試管療程前 2-3 個月開始補充，劑量遠超過台灣食藥署 30mg/日上限。
💬社群實感
多數正面
破解迷思 社群最常見的 5 個誤解
✓
事實誤以為 Q10 劑量越高越好（實際上 400mg 以上多人出現腸胃不適）
✓
事實不分還原型 (Ubiquinol) 與氧化型 (Ubiquinone)，導致實際吸收量不足
✓
事實誤以為衛福部 30mg/日上限是備孕有效劑量（實際備孕劑量需 200-600mg）
✓
事實誤以為 Q10 可立即見效（實際需持續 3 個月以上才支持完整養卵週期）
✓
事實忽略複方添加物，肌瘤患者誤服含月見草油/大豆卵磷脂版本
🩹 社群通報的副作用
- 腸胃不適（噁心、腹瀉，常見於 400mg 以上）
- 胃痛（部分品牌複方成分引發）
- 失眠（過量時）
- 頭暈、疲勞
- 抗凝血作用，服用抗凝血藥物者需注意
🏷️ 社群熱議品牌
依論壇被提及頻率，非銷售或品質排序。
- Jarrow Formulas
- Doctor's Best
- 萊萃美 (Nature Made)
- DHC（日版）
- 21st Century
- 活力媽媽倍韻
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 孕前葉酸補充 (400-800 ug/d)
- 排卵誘導 (letrozole)
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-female-fertility-INT-coenzyme-q10-001/",
"datePublished": "2026-06-09",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "輔酶 Q10 (輔酵素 Q10)能改善女性生育力",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 3,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟡 B 初步證據"
}
}